You would think the drug would have some value to a company with an existing CV sales force. It’s a tough sell though going against statins w decades of safety and efficacy. I changed from Lipitor to Crestor bc of cramps and am doing fine. I would probably take nexletol if I couldn’t tolerate any statin but I would try and get a PCSK9 first
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.